Carolyn Bertozzi

Carolyn Bertozzi

Director/Miembro de la Junta en OMNIAB, INC. .

Fortuna: 27 M $ al 31/10/2026

59 años
Health Technology
Commercial Services
Consumer Services

Perfil

Carolyn R.
Bertozzi
is the founder of Redwood Bioscience, Inc. founded in 2008.
Dr. Bertozzi is the founder of Palleon Pharmaceuticals, Inc. founded in 2015.
Dr. Bertozzi was the founder of Enable Biosciences, Inc. founded in 2016 and served as Chairman.
Dr. Bertozzi is the founder of Venn Biosciences Corp.
founded in 2017.
Dr. Bertozzi is the founder of Lycia Therapeutics, Inc. founded in 2019.
Dr. Bertozzi is the founder of Valora Therapeutics, Inc. founded in 2023.
Dr. Bertozzi is the founder of TwoStep Therapeutics, Inc. founded in 2024.
Dr. Bertozzi is also the founder of Firefly Bio, Inc...
Dr. Bertozzi is currently Director at Grace Science Foundation, Independent Director at OmniAb Operations, Inc., Independent Director at OmniAb, Inc. since 2022, Director at Stanford Chem-H since 2021, Director at Xaira Therapeutics, Inc., Independent Director at Eli Lilly & Co. starting 2025, Professor at Stanford University, and Member of American Chemical Society, The Royal Society, National Academy of Sciences, American Academy of Arts & Sciences, National Academy of Medicine (United States), American Society for Biochemistry & Molecular Biology, Inc., Accademia Nazionale dei Lincei, and National Academy of Inventors.
Former positions include Independent Director at Eli Lilly & Co. from 2017 to 2021, Director-Molecular Foundry at Lawrence Berkeley National Laboratory, Director at The Broad Institute, Inc., Director at Catalent, Inc., Director at Molecular Foundry, Independent Director at Alnylam Pharmaceuticals, Inc. from 2023 to 2025, Professor at the University of California, Berkeley from 1996 to 2015, and Professor at Howard Hughes Medical Institute, Inc. Education includes an undergraduate degree from Harvard University conferred in 1988 and a doctorate from the University of California, Berkeley conferred in 1993.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
22/10/2026 904.821 ( 1,57 % ) 24 M $ 31/10/2026
25/02/2026 2.000 ( 0 % ) 3 M $ 31/10/2026
17/06/2026 113.308 ( 0,08 % ) 579 004 $ 31/10/2026
08/05/2025 775 ( 0 % ) 127 875 $ 31/10/2026

Cargos activos de Carolyn Bertozzi

EmpresasCargoInicio
OMNIAB, INC. Director/Miembro de la Junta 01/11/2022
ELI LILLY AND COMPANY Director/Miembro de la Junta 08/12/2025
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Stanford Chem-H
Director/Miembro de la Junta 01/01/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Antiguos cargos conocidos de Carolyn Bertozzi.

EmpresasCargoFin
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Ver el detalle de la experiencia de Carolyn Bertozzi.

Formación de Carolyn Bertozzi.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

88

Relaciones de 1er grado

28

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas28

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Miscellaneous

Miscellaneous

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Stanford Chem-H

Health Technology

Health Services

Health Technology

Commercial Services

Molecular Foundry

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Carolyn Bertozzi